| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 78.95▲ | 78.85▲ | 78.78▲ | 78.84▲ | 79.52▼ |
| MA10 | 78.88▲ | 78.64▲ | 78.65▲ | 79.03▲ | 82.03▼ |
| MA20 | 78.76▲ | 78.57▲ | 78.71▲ | 79.60▼ | 84.03▼ |
| MA50 | 78.60▲ | 78.63▲ | 78.82▲ | 82.47▼ | 71.99▲ |
| MA100 | 78.61▲ | 78.84▲ | 79.44▼ | 83.74▼ | 69.71▲ |
| MA200 | 78.67▲ | 79.46▼ | 81.36▼ | 73.63▲ | 68.38▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | 0.065▲ | 0.071▲ | 0.067▲ | -1.588▼ |
| RSI | 63.253▲ | 60.701▲ | 55.235▲ | 43.296▼ | 49.747▼ |
| STOCH | 73.078 | 85.130▲ | 80.409▲ | 46.466 | 20.192 |
| WILL %R | -6.186▲ | -3.109▲ | -2.113▲ | -47.435 | -78.666▼ |
| CCI | 125.585▲ | 141.782▲ | 141.573▲ | -50.701 | -122.212▼ |
|
Thursday, March 23, 2023 02:57 PM
The chairman and CEO of the HIV, hepatitis and cancer drug developer saw the smallest percentage uptick in annual compensation among the Foster City-based company's executive officers.
|
|
Thursday, March 23, 2023 01:36 PM
Gilead trims "myeloid tuning" cancer drug deal with Pionyr, retains stake, frees partner to pursue more cash and collaborations ...
|
|
Thursday, March 23, 2023 10:52 AM
The biotech sector has been in focus in the past week with key pipeline and regulatory updates. Among these, Incyte’s INCY skin cancer drug obtained FDA approval. Altimmune ALT declined on mixed ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/03/23 | 78.92 | 79.065 | 78.33 | 79.035 | 990,777 |
| 23/03/23 | 77.78 | 78.93 | 77.65 | 78.76 | 5,015,742 |
| 22/03/23 | 79.10 | 79.38 | 77.76 | 77.81 | 4,406,020 |
| 21/03/23 | 79.53 | 80.05 | 78.36 | 79.14 | 4,744,800 |
| 20/03/23 | 77.71 | 79.67 | 77.63 | 79.46 | 4,672,679 |
| 17/03/23 | 79.76 | 79.76 | 76.525 | 77.31 | 16,828,078 |
| 16/03/23 | 79.18 | 79.97 | 78.42 | 79.85 | 6,004,405 |
| 15/03/23 | 79.10 | 79.89 | 78.53 | 79.65 | 4,875,419 |
| 14/03/23 | 79.03 | 79.91 | 78.32 | 79.77 | 5,498,400 |
| 13/03/23 | 78.565 | 81.27 | 78.565 | 79.51 | 6,845,669 |
|
|
||||
|
|
||||
|
|